Nacuity Pharmaceuticals, Inc.
Clinical trials sponsored by Nacuity Pharmaceuticals, Inc., explained in plain language.
-
New hope for rare disease: testing alternative to harsh current treatment
Disease control Recruiting nowThis early-stage study is testing a new oral medication called NPI-001 for people with cystinosis, a rare genetic disorder. It will compare NPI-001's safety and its ability to lower harmful cystine levels in the body to the current standard treatment, cysteamine. The study involv…
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New eye implant aims to put the brakes on cataracts
Disease control Recruiting nowThis study is testing a tiny implant placed inside the eye to see if it can safely slow down the worsening of cataracts in people who have had vitrectomy surgery. It will involve about 30 patients who already have some cataract and are scheduled for this specific eye procedure. R…
Phase: PHASE1, PHASE2 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC